Cytogenix (fka CYGX)

[doublekoko]

The Company has entered an agreement with GE Healthcare Bio-Sciences Corp.
whereas GEHC will provide the Company with DNA production reagents for use in
the manufacture of vaccines and therapeutic compounds. The Company is in the
process of negotiating with GEHC to renew and extend the Agreement. As of the
date of this filing no agreement has been finalized.

i like tgis because it could be the funding they need, we know they have had a relationship and GE already understands how good the technology is. If they are in negotiations, one could probably assume that GE is going to and will continue to use our DNA production reagents. could there be money in here?